hydroxyurea has been researched along with Venous Thrombosis in 18 studies
Venous Thrombosis: The formation or presence of a blood clot (THROMBUS) within a vein.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Venous thrombosis is more frequent in PV than in ET; superficial or deep venous thromboses are seen." | 2.41 | [What vascular events suggest a myeloproliferative disorder?]. ( Caulier-Leleu, MT; Hachulla, E; Pasturel-Michon, U; Rose, C; Trillot, N, 2000) |
| "We recorded 348 recurrences (venous in 142 cases) over 6075 patient-years, with an incidence rate of 5." | 1.48 | Hydroxyurea prevents arterial and late venous thrombotic recurrences in patients with myeloproliferative neoplasms but fails in the splanchnic venous district. Pooled analysis of 1500 cases. ( Barbui, T; Betti, S; Carobbio, A; De Stefano, V; Finazzi, G; Ghirardi, A; Rossi, E; Vannucchi, AM, 2018) |
| "Previous thrombosis is an established risk factor for rethrombosis in patients with ET." | 1.38 | Cerebral infarct in a patient with a history of systemic arterial and venous thrombosis from essential thrombocythemia. ( Cho, KH; Kim, KT; Sohn, SI, 2012) |
| "Idiopathic hypereosinophilic syndrome is a rare condition characterized by extremely high peripheral blood eosinophil counts." | 1.33 | Factor V Leiden mutation and deep venous thrombosis in a patient with hypereosinophilic syndrome. ( Aslan, V; Entok, E, 2006) |
| "Treatment with prednisolone and azathioprine was initiated." | 1.30 | [Pyoderma gangrenosum and portal vein thrombosis in a 33-year-old female patient]. ( Berr, F; Halm, U; Mössner, J; Paasch, U; Pönisch, W; Schiefke, I, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 11 (61.11) | 29.6817 |
| 2010's | 5 (27.78) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Ladeira, VS | 1 |
| Barbosa, AR | 1 |
| Oliveira, MM | 1 |
| Ferreira, LGR | 1 |
| de Oliveira Júnior, WV | 1 |
| de Oliveira Renó, C | 1 |
| Reis, EA | 1 |
| Chaves, DG | 1 |
| Dusse, LMS | 1 |
| Dos Santos, HL | 1 |
| de Barros Pinheiro, M | 1 |
| Rios, DRA | 1 |
| Karam, D | 1 |
| Iyer, V | 1 |
| Agrawal, B | 1 |
| De Stefano, V | 2 |
| Rossi, E | 1 |
| Carobbio, A | 1 |
| Ghirardi, A | 2 |
| Betti, S | 1 |
| Finazzi, G | 3 |
| Vannucchi, AM | 2 |
| Barbui, T | 3 |
| Masciulli, A | 1 |
| Allegra, A | 1 |
| Alonci, A | 1 |
| Penna, G | 1 |
| D'Angelo, A | 1 |
| Rizzotti, P | 1 |
| Granata, A | 1 |
| Musolino, C | 1 |
| Lukina, EA | 1 |
| Sysoeva, EP | 1 |
| Kitsenko, EA | 1 |
| Varlamova, EIu | 1 |
| Inozemtseva, MV | 1 |
| Semenova, EA | 1 |
| Nadinskaia, MIu | 1 |
| Ivashkin, VT | 1 |
| Kim, KT | 1 |
| Sohn, SI | 1 |
| Cho, KH | 1 |
| Ince, AT | 1 |
| Bölükbaş, C | 1 |
| Dalay, R | 1 |
| Sökmen, HM | 1 |
| Kurdaş, OO | 1 |
| Aslan, V | 1 |
| Entok, E | 1 |
| Messouak, O | 1 |
| Alaoui Faris, M | 1 |
| Benabdejlil, M | 1 |
| Tizniti, S | 1 |
| Belahsen, F | 1 |
| Landolfi, R | 1 |
| Di Gennaro, L | 1 |
| Schiefke, I | 1 |
| Halm, U | 1 |
| Paasch, U | 1 |
| Pönisch, W | 1 |
| Berr, F | 1 |
| Mössner, J | 1 |
| Randi, ML | 1 |
| Rossi, C | 1 |
| Fabris, F | 1 |
| Girolami, A | 1 |
| Schaefer, U | 1 |
| Micke, O | 1 |
| Schueller, P | 1 |
| Willich, N | 1 |
| Hachulla, E | 1 |
| Rose, C | 1 |
| Trillot, N | 1 |
| Caulier-Leleu, MT | 1 |
| Pasturel-Michon, U | 1 |
| Jantunen, R | 1 |
| Juvonen, E | 1 |
| Ikkala, E | 1 |
| Oksanen, K | 1 |
| Anttila, P | 1 |
| Ruutu, T | 1 |
| Das, R | 1 |
| Kaur, U | 1 |
| Garewal, G | 1 |
2 reviews available for hydroxyurea and Venous Thrombosis
| Article | Year |
|---|---|
Special issues in myeloproliferative neoplasms.
Topics: Antineoplastic Agents; Cell Transformation, Neoplastic; Child; Female; Hemorrhage; Humans; Hydroxyur | 2011 |
[What vascular events suggest a myeloproliferative disorder?].
Topics: Adult; Aged; Alkylating Agents; Arterial Occlusive Diseases; Cross-Sectional Studies; Erythromelalgi | 2000 |
1 trial available for hydroxyurea and Venous Thrombosis
| Article | Year |
|---|---|
ADAMTS-13-VWF axis in sickle cell disease patients.
Topics: ADAMTS13 Protein; Adolescent; Adult; Anemia, Sickle Cell; Cross-Sectional Studies; Female; Humans; H | 2021 |
15 other studies available for hydroxyurea and Venous Thrombosis
| Article | Year |
|---|---|
Occult myeloproliferative neoplasms: not so occult any more.
Topics: Adult; Bone Marrow; Budd-Chiari Syndrome; Calreticulin; Enzyme Inhibitors; Humans; Hydroxyurea; Janu | 2017 |
Hydroxyurea prevents arterial and late venous thrombotic recurrences in patients with myeloproliferative neoplasms but fails in the splanchnic venous district. Pooled analysis of 1500 cases.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Hydroxyurea; Incidence; Male; Middle Aged; Myeloprol | 2018 |
Different effect of hydroxyurea and phlebotomy on prevention of arterial and venous thrombosis in Polycythemia Vera.
Topics: Humans; Hydroxyurea; Incidence; Phlebotomy; Polycythemia Vera; Thrombosis; Treatment Outcome; Venous | 2018 |
JAK2 V617F-positive latent essential thrombocythemia and splanchnic vein thrombosis: the role of bone marrow biopsy for the diagnosis of myeloproliferative disease.
Topics: Abdominal Pain; Acenocoumarol; Adult; Anticoagulants; Biopsy; Bone Marrow; Bone Marrow Examination; | 2009 |
[Syndrome of extrahepatic portal hypertension and chronic abdominal ischemia in patient with subleukemic myelosis and congenital immunodeficiency].
Topics: Abdomen; Adult; Anticoagulants; Antineoplastic Agents; Chronic Disease; Female; Humans; Hydroxyurea; | 2009 |
Cerebral infarct in a patient with a history of systemic arterial and venous thrombosis from essential thrombocythemia.
Topics: Arterial Occlusive Diseases; Biopsy; Bone Marrow Examination; Cerebral Angiography; Cerebral Infarct | 2012 |
Rapid resolution of portal vein thrombosis and noncirrhotic portal hypertension following cyto-reductive therapy in a patient with chronic myeloid leukemia.
Topics: Aged; Antineoplastic Agents; Female; Humans; Hydroxyurea; Hypertension, Portal; Leukapheresis; Leuke | 2003 |
Factor V Leiden mutation and deep venous thrombosis in a patient with hypereosinophilic syndrome.
Topics: Adult; Anticoagulants; Coumarins; Enzyme Inhibitors; Factor V; Heparin, Low-Molecular-Weight; Humans | 2006 |
[Cerebral venous thrombosis secondary to essential thrombocythemia].
Topics: Adolescent; Allopurinol; Brain; Cerebral Veins; Drug Therapy, Combination; Enzyme Inhibitors; Female | 2007 |
Prevention of thrombosis in polycythemia vera and essential thrombocythemia.
Topics: Arterial Occlusive Diseases; Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; | 2008 |
[Pyoderma gangrenosum and portal vein thrombosis in a 33-year-old female patient].
Topics: Adult; Anti-Inflammatory Agents; Anticoagulants; Antineoplastic Agents; Ascites; Azathioprine; Bone | 1999 |
Essential thrombocythemia in young adults: major thrombotic complications and complications during pregnancy--a follow-up study in 68 patients.
Topics: Acute Disease; Adult; Age Factors; Arteriosclerosis; Aspirin; Busulfan; Cohort Studies; Disease-Free | 2000 |
Recurrent head and neck cancer: retreatment of previously irradiated areas with combined chemotherapy and radiation therapy-results of a prospective study.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy P | 2000 |
The predictive value of vascular risk factors and gender for the development of thrombotic complications in essential thrombocythemia.
Topics: Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Blood Platelets; Busulfan; Female; Huma | 2001 |
Splenectomy in a case of splenic vein thrombosis unmasks essential thrombocythemia.
Topics: Adult; Hematemesis; Humans; Hydroxyurea; Hypertension, Portal; Ischemic Attack, Transient; Male; Pla | 2002 |